📖

Alzheimer's Disease VEGF/Angiogenic Signaling and Cerebral Blood Flow Therapy Companies

wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-companies-ad-vegf-angiogenic-signal

Related Entities

companies-ad-vegf-angiogenic-signaling-therapy-companies

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

531

Outgoing

545

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Linked Artifacts (665)

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%

see_also📖IGC-AD1 for Agitation in Alzheimer's Disease (NCT05543680%

see_also📖NCT07262645: Near-Infrared Light Therapy for Mild-Moderate A80%

see_also📖CBD (Cannabidiol) for Alzheimer's Disease Agitation - N80%

see_also📖SToP-AD: Suvorexant for Alzheimer's Disease Prevention80%

see_also📖Tau Kinase-Phosphatase Balance in Alzheimer's Disease80%

see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease80%

see_also📖EEG Biomarkers for Alzheimer's Disease80%

see_also📖Synaptic Loss in Alzheimer's Disease Pathway80%

see_also📖Biogen Alzheimer's Disease Phase 2 Trial (NCT05399888)80%

see_also📖Endolysosomal Pathway in Alzheimer's Disease80%

see_also📖NLRP3 Inflammasome Pathway in Alzheimer's Disease80%

see_also📖Diffuse Amyloid Deposits in Alzheimer's Disease80%

see_also📖Synaptic Biomarkers for Alzheimer's Disease80%

see_also📖Escitalopram for Agitation in Alzheimer's Disease (NCT080%

see_also📖NCT03875638 - Levetiracetam for Alzheimer's Disease80%

see_also📖Senicapoc Alzheimer's Disease Trial - NCT0480424180%

see_also📖CD33 Siglec Receptor Dysfunction Alzheimer's Disease Ca80%

see_also📖Piromelatine 20 mg for Mild Dementia Due to Alzheimer's80%

see_also📖Alzheimer's Disease Mechanism Index80%

see_also📖Neurovascular Dysfunction in Alzheimer's Disease: Integ80%

see_also📖KarXT (Xanomeline/Trospium) - Phase 3 for Alzheimer's D80%

see_also📖Mitochondrial Dysfunction in Alzheimer's Disease Pathwa80%

see_also📖Latrepirdine (DMB-I) Phase 3 Trial for Alzheimer's Dise80%

see_also📖EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer80%

see_also📖Ozanimod for Alzheimer's Disease (NCT06862960)80%

see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI80%

see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451680%

see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease80%

see_also📖Eye-Tracking Digital Markers in Alzheimer's Disease80%

see_also📖Master Screening Study to Determine Individuals With Potenti80%

see_also📖Fasudil for Early Alzheimer's Disease (FEAD) - NCT0636280%

see_also📖Locus Coeruleus Degeneration in Alzheimer's Disease80%

see_also📖NRTIs for Alzheimer's Disease - Phase 1 (NCT07210528)80%

see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058280%

see_also📖DTI Biomarkers for Alzheimer's Disease80%

see_also📖Nabilone for Agitation in Alzheimer's Disease (NCT0451680%

see_also📖MAR Polypill for Alzheimer's Disease (NCT06597058)80%

see_also📖GFAP in Alzheimer's Disease80%

see_also📖Salivary Biomarkers for Alzheimer's Disease80%

see_also📖Vascular Dementia Mechanisms — Overlap with Alzheimer's80%

see_also📖Gait Biomarkers for Alzheimer's Disease80%

see_also📖Cholinergic System Degeneration in Alzheimer's Disease80%

see_also📖ASN90 Phase 2 Trial - Early Alzheimer's Disease (NCT05680%

see_also📖DMB-I (Latrepirdine) Phase 3 (NCT07251023) — Alzheimer'80%

see_also📖Digital Biomarkers for Alzheimer's Disease80%

see_also📖APOE4 and Alzheimer's Disease Risk80%

see_also📖PLX5622 CSF1R Inhibitor Trial in Early Alzheimer's Dise80%

see_also📖ASL Perfusion Biomarkers for Alzheimer's Disease80%

see_also📖Inflammatory Biomarkers in Alzheimer's Disease80%

see_also📖Alzheimer's Disease Biomarkers80%

see_also📖NAB-IT: Nabilone for Agitation in Alzheimer's Disease80%

see_also📖Recombinant Human Serum Albumin for Alzheimer's Disease80%

see_also📖VY7523 Phase 1/2 Alzheimer's Disease Trial80%

see_also📖MK-2214 for Early Alzheimer's Disease80%

see_also📖[F-18]Flornaptitril PET - Phase 3 for Alzheimer's Disea80%

see_also📖Foralumab Phase 2 Trial for Alzheimer's Disease80%

see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI80%

see_also📖Glymphatic System in Alzheimer's Disease80%

see_also📖SHR-1707 for Alzheimer's Disease (NCT06199037)80%

see_also📖BIIB080 (MAPTRx) Antisense Oligonucleotide for Alzheimer80%

see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease80%

see_also📖Ubiquitin-Proteasome System Dysfunction in Alzheimer's 80%

see_also📖Probiotics in Mild Alzheimer's Disease (NCT06181513)80%

see_also📖Masupirdine for Agitation in Alzheimer's Disease (NCT0580%

see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease80%

see_also📖BMS-986368 Phase 2 - Agitation in Alzheimer's Disease80%

see_also📖LEAF Trial - THC+CBD for Alzheimer's Disease Agitation 80%

see_also📖BMS-986446 Phase 2 Trial for Early Alzheimer's Disease80%

see_also📖Tear Film Biomarkers in Alzheimer's Disease80%

see_also📖TRAILBLAZER-ALZ 3 (NCT05026866) — Donanemab for Preclinical 80%

see_also📖SNIFF-Combo: Intranasal Insulin + Empagliflozin for Alzheime80%

see_also📖Neuroinflammation Hypothesis in Alzheimer's Disease80%

see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh80%

see_also📖NCT06582706: Nicotinic Acid for Alzheimer's Disease80%

see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime80%

see_also📖Metal Ion Homeostasis in Alzheimer's Disease80%

see_also📖Geniposide for Alzheimer's disease - immune biomarker t80%

see_also📖Sleep Biomarkers for Alzheimer's Disease80%

see_also📖Exciva Alzheimer's Disease Phase 2/3 Trial80%

see_also📖Ocular Fluid Biomarkers for Alzheimer's Disease80%

see_also📖ExPlas — Exercise Plasma Transfusion for Alzheimer's Di80%

see_also📖ACP-204 for Alzheimer's Disease Psychosis (NCT06159673)80%

see_also📖Masupirdine for Alzheimer's Disease Agitation80%

see_also📖ITI-1284 for Alzheimer's Disease Psychosis (NCT0654083380%

see_also📖LHP588: P. gingivalis Targeting for Alzheimer's Disease80%

see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di80%

see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers80%

see_also📖TRAP-AD: Transcranial Photobiomodulation for Alzheimer'80%

see_also📖Plasma Phospho-Tau Ratio Diagnostic Panel for Alzheimer'80%

see_also📖X/T + X-EC + Lecanemab Phase 2 (NCT07212062) — Alzheimer80%

see_also📖Siponimod for Alzheimer's Disease (NCT06639282)80%

see_also📖GV1001 for Moderate to Severe Alzheimer's Disease (NCT080%

see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St80%

see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 80%

see_also📖Sex-Specific Mechanisms in Alzheimer's Disease80%

see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0680%

see_also📖Olfactory Biomarkers for Alzheimer's Disease80%

see_also📖Neuroinflammation in Alzheimer's Disease80%

see_also📖NCT06803823 - ONO-2020 for Agitation in Alzheimer's Dis80%

see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06780%

see_also📖Centella asiatica Phase 1 Trial for Alzheimer's Disease80%

see_also📖APOE Lipid Metabolism Pathway in Alzheimer's Disease80%

see_also📖Neurogranin - Alzheimer's Disease Biomarker80%

see_also📖Dried Blood Spot Biomarker Test for Alzheimer's Disease80%

see_also📖EEG Microstates in Alzheimer's Disease80%

see_also📖Guanfacine NorAD - Phase 3 Trial for Alzheimer's Diseas80%

see_also📖The Alzheimer's Disease Tau Platform Clinical Trial (NC80%

see_also📖Sporadic Alzheimer's Disease Pathway80%

see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime80%

see_also📖NRTIs for Alzheimer's Disease: Targeting Type-I Interfe80%

see_also📖ONO-2020 for Alzheimer's Disease (NCT06881836)80%

see_also📖Endosomal Sorting Defects in Neurodegeneration75%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration75%

see_also📖Senescent Cell Clearance in Neurodegeneration75%

see_also📖Neural Circuit Disruption in Neurodegeneration75%

see_also📖IL-1 Signaling Pathway in Neurodegeneration70%

mentions🧪Circadian-Synchronized LRP1 Pathway Activation70%

see_also📖HMGB1 Signaling in Neurodegeneration70%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming70%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread70%

see_also📖Antibody Therapy in Neurodegeneration70%

see_also📖Therapeutic Targets in Neurodegeneration70%

see_also📖Retinal Degeneration Pathway in Neurodegeneration70%

see_also📖Axon Guidance Pathways in Neurodegeneration70%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration70%

see_also📖RNA-Targeted Therapies in Neurodegeneration70%

mentions🧪Mechanosensitive Ion Channel Reprogramming70%

see_also📖Galectin-3 Mechanism in Neurodegeneration70%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration70%

see_also📖COVID-19 Neurodegeneration Mechanism70%

see_also📖Convergent Pathways in Neurodegeneration70%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration70%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration70%

see_also📖Down Syndrome Neurodegeneration Pathway70%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration70%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration70%

mentions🧪Lipid Droplet Dynamics as Phenotype Switches70%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration70%

see_also📖Microglial Priming Pathway in Neurodegeneration70%

mentions🧪Purinergic Signaling Polarization Control70%

see_also📖Sex Differences in Neurodegeneration70%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration70%

see_also📖PPAR Signaling Pathway in Neurodegeneration70%

see_also📖Dystrophic Neurites in Neurodegeneration70%

see_also📖T-Cell Dysfunction in Neurodegeneration65%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration65%

see_also📖Diffusion MRI (DTI) in Neurodegeneration65%

see_also📖Prion-Like Spread in Neurodegeneration65%

see_also📖Paraptosis in Neurodegeneration65%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration65%

see_also📖Amylin Signaling in Neurodegeneration65%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N65%

see_also📖Integrated Stress Response in Neurodegeneration65%

see_also📖Molecular Chaperones in Neurodegeneration65%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration65%

see_also📖Endothelin Signaling Pathway in Neurodegeneration65%

see_also📖GDNF Signaling Pathway in Neurodegeneration65%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)65%

see_also📖Economic Burden — Neurodegeneration65%

see_also📖mTOR Signaling in Neurodegeneration65%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration65%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration65%

see_also📖Liquid Biopsy in Neurodegeneration65%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration65%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration65%

see_also📖Hippocampal Neurogenesis in Neurodegeneration65%

see_also📖synaptic-vesicle-cycling-neurodegeneration65%

see_also📖Progesterone Signaling Pathway in Neurodegeneration65%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)65%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration65%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration65%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen65%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration65%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 65%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)65%

see_also📖Manganese-Related Neurodegeneration (Manganism)65%

see_also📖Autosis Pathway in Neurodegeneration65%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio65%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 65%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 65%

see_also📖Neuroimaging Biomarkers for Neurodegeneration65%

see_also📖acetylcholine-signaling-neurodegeneration65%

see_also📖RNA Splicing in Neurodegeneration65%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration65%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration65%

see_also📖Computational Disease Models for Neurodegeneration65%

see_also📖Neural Circuits in Neurodegeneration65%

see_also📖Gangliosides in Neurodegeneration65%

see_also📖Ribosome Dysfunction in Neurodegeneration65%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration65%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat65%

see_also📖Exosomal Biomarkers in Neurodegeneration65%

see_also📖PKR Pathway in Neurodegeneration65%

see_also📖Pericyte Loss in Neurodegeneration65%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration65%

see_also📖China Neurodegeneration Epidemiology65%

see_also📖epigenetics-neurodegeneration65%

see_also📖SUMOylation in Neurodegeneration65%

see_also📖Sleep Disorders in Neurodegeneration65%

see_also📖Protein Aggregation Seeds in Neurodegeneration65%

see_also📖Histone Modification Pathways in Neurodegeneration65%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration65%

see_also📖Vagus Nerve Pathway in Neurodegeneration65%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati65%

see_also📖Glycosylation in Neurodegeneration65%

see_also📖CaMKII Signaling Pathway in Neurodegeneration65%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration65%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration65%

see_also📖Prion Protein Metabolism in Neurodegeneration65%

see_also📖RAN Translation in Neurodegeneration65%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration65%

see_also📖Prion Diseases in Neurodegeneration65%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration65%

see_also📖Sleep Dysfunction in Neurodegeneration65%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration65%

see_also📖Exosomal miR-155 in Neurodegeneration65%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration65%

see_also📖Lipid Dysregulation in Neurodegeneration65%

see_also📖R-Loop Stress in Neurodegeneration65%

see_also📖Potential Impact Measures — Neurodegeneration65%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration65%

see_also📖Metabolomic Biomarkers in Neurodegeneration65%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration65%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)65%

see_also📖Orexin Signaling in Neurodegeneration65%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a65%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration65%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration65%

see_also📖FA2H-Associated Neurodegeneration Pathway65%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su65%

see_also📖Purinergic Signaling in Neurodegeneration65%

see_also📖mTOR Signaling Pathway in Neurodegeneration65%

see_also📖Digital Phenotyping in Neurodegeneration65%

see_also📖Synaptic Biomarkers in Neurodegeneration65%

see_also📖European Neurodegeneration Epidemiology65%

see_also📖Paranodal Dysfunction in Neurodegeneration65%

see_also📖Metal Homeostasis in Neurodegeneration65%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration65%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio65%

see_also📖Global Neurodegeneration Epidemiology65%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration65%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr65%

see_also📖WNK1 Kinase in Neurodegeneration65%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener65%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration65%

see_also📖Parthanatos in Neurodegeneration65%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison65%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration65%

see_also📖Neuropil Threads in Neurodegeneration65%

see_also📖Neuronal Hyperexcitability in Neurodegeneration65%

see_also📖Nitric Oxide Signaling in Neurodegeneration65%

see_also📖Kidney-Brain Neurodegeneration Axis65%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration65%

see_also📖US Neurodegeneration Epidemiology65%

see_also📖Disease Progression & Staging in Neurodegeneration65%

see_also📖India Neurodegeneration Epidemiology65%

see_also📖Copper Homeostasis in Neurodegeneration65%

see_also📖interleukin-6-signaling-neurodegeneration65%

see_also📖Protein Aggregation Comparison in Neurodegeneration65%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration65%

see_also📖Familial vs Sporadic Neurodegeneration Comparison65%

see_also📖Japan Neurodegeneration Epidemiology65%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain65%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and65%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration65%

see_also📖MicroRNA Dysfunction in Neurodegeneration65%

see_also📖Endocannabinoid System in Neurodegeneration65%

see_also📖Short Chain Fatty Acids in Neurodegeneration65%

see_also📖NRF2 Signaling Pathway in Neurodegeneration65%

see_also📖Cholinergic System Dysfunction in Neurodegeneration65%

see_also📖NF-kB Signaling Pathway in Neurodegeneration65%

see_also📖DALY Methodology — Neurodegeneration65%

see_also📖Advanced Glycation End Products in Neurodegeneration65%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)65%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 65%

see_also📖Mitochondrial Fusion in Neurodegeneration65%

see_also📖Neuropeptide Y Signaling in Neurodegeneration65%

see_also📖Neurotensin Signaling in Neurodegeneration65%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl65%

see_also📖Prognostic Biomarkers in Neurodegeneration65%

see_also📖Serotonergic Dysfunction in Neurodegeneration65%

see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas60%

see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc60%

related🧫Tau ASO Therapy60%

see_also📖Systemic Infection and Tau Pathology Acceleration55%

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE55%

see_also📖Blood-Brain Barrier and Neuroimmune Interface in CBS/PSP55%

see_also📖Long-term Effects of Hearing Intervention on Brain Health in55%

see_also📖ABCA7 Lipid Transport and Microglial Phagocytosis AD Causal 55%

see_also📖Neuroinflammation in Parkinson's Disease Dementia and D55%

see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial55%

see_also📖Tau Seeding and Propagation Pathway55%

see_also📖Blood-Brain Barrier Dysfunction and Therapeutic Delivery for55%

related🧫Tau ASO Therapy54%

see_also📖C9orf72 Repeat Expansions in CBS and PSP50%

mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%

mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%

mentions🧪Aquaporin-4 Polarization Rescue50%

see_also📖Glymphatic Clearance Hypothesis — Impaired Aβ and Tau Remova50%

see_also📖Glymphatic and Vascular Clearance Dysfunction in 4R-Tauopath50%

see_also📖CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subc50%

see_also📖PSP and Idiopathic Normal Pressure Hydrocephalus: Clinical O50%

mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%

see_also📖Digital Therapeutic Platform for Swallowing and Drooling Pro50%

see_also📖A 6-month & 18-month Prospective, Randomized, Placebo-co50%

see_also📖Myoclonus and Cortical Hyperexcitability in Corticobasal Syn50%

mentions🧪Trans-Synaptic Adhesion Molecule Modulation50%

mentions🧪Synaptic Vesicle Tau Capture Inhibition50%

mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%

mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%

mentions🧪Glial Glycocalyx Remodeling Therapy50%

see_also📖Braak Staging and Tau Propagation Pathway50%

mentions🧪TREM2-mediated microglial tau clearance enhancement50%

mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%

see_also📖Advanced Proteolysis and Ubiquitin System Targeting in CBS/P50%

mentions🧪Arginine Methylation Enhancement Therapy50%

mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%

see_also📖CBS/PSP Panxoneopathy and Membrane Biology50%

see_also📖Shared Mechanisms Between Alzheimer and Parkinson Disease50%

see_also📖PCDH19-Related Epilepsy (EFMR) — Preclinical Gene Therapy Pr50%

see_also📖Mirror Therapy and Sensory Re-education in Corticobasal Synd50%

see_also📖Speech Therapy and Communication Aids in Corticobasal Syndro50%

mentions🧪R-Loop Resolution Enhancement Therapy50%

see_also📖Phase 3 Study to Compare the Efficacy and Safety of Masitini50%

mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%

mentions🧪VCP-Mediated Autophagy Enhancement50%

mentions🧪Blood-Brain Barrier SPM Shuttle System50%

see_also📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi50%

see_also📖Hereditary Sensory and Autonomic Neuropathy (HSAN)50%

see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M50%

see_also📖p-Tau Biomarker in Immunoglobulin Light Chain and Transthyre50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Orexin-Microglia Modulation Therapy50%

see_also📖Glial Tau Pathology in PSP and CBD50%

see_also📖Multimodal Diagnostic Algorithm for CBS and PSP50%

see_also📖mTOR Signaling in Autophagy and Lysosomal Function50%

mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%

see_also📖FTLD-TDP Subtypes and Mechanisms50%

mentions🧪Extracellular Vesicle Biogenesis Modulation50%

see_also📖ALS Therapeutic Landscape — Programs by Phase and Modality50%

mentions🧪LRP1-Dependent Tau Uptake Disruption50%

mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%

mentions🧪HSP90-Tau Disaggregation Complex Enhancement50%

mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%

see_also📖Neuroresilience Mechanisms and Evidence50%

see_also📖HLA Haplotypes and Neuroinflammatory Profiles in PSP50%

mentions🧪Lysosomal Calcium Channel Modulation Therapy50%

see_also📖Physical and Occupational Therapy in Corticobasal Syndrome50%

mentions🧪Complement C1q Mimetic Decoy Therapy50%

mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%

mentions🧪CYP46A1 Overexpression Gene Therapy50%

see_also📖APOE4 (Apolipoprotein E4)50%

mentions🧪PARP1 Inhibition Therapy50%

mentions🧪Prefrontal sensory gating circuit restoration via PV interne50%

see_also📖A Multicenter, Phase III, Randomized, Double Blind, Placebo-50%

see_also📖Healthcare Economics and Cost of Illness in Progressive Supr50%

mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%

mentions🧪Ganglioside Rebalancing Therapy50%

see_also📖Utilisation of Health Services and Quality of Life in Atypic50%

see_also📖MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acid50%

see_also📖Synaptic Loss and Dysfunction Pathway50%

see_also📖ATP13A9 and Parkinson's Disease45%

see_also📖Sialorrhea and Drooling in Corticobasal Syndrome45%

see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 45%

see_also📖Dysphagia and Nutritional Management in Corticobasal Syndrom45%

see_also📖NLRP3 Inflammasome Inhibitors for Parkinson's Disease45%

see_also📖SNCA — Alpha-Synuclein Gene Entity Page45%

see_also📖Natural History and Prognosis of Corticobasal Syndrome45%

see_also📖Polygenic Risk Score Integration Panel for Alzheimer's 45%

see_also📖Clinical Efficacy and Mechanism of tDCS for Dysphagia in Par45%

see_also📖Investment Landscape: Frontotemporal Dementia45%

see_also📖Pupillometry and Chromatic Pupillometry in Corticobasal Synd45%

see_also📖Gene-Mechanism-Therapy Causal Chains45%

see_also📖Caregiver Burden and Support in Corticobasal Syndrome45%

see_also📖MSA Clinical Features and Diagnosis45%

see_also📖PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical AD45%

see_also📖Investment Landscape: Parkinson's Disease45%

see_also📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo45%

see_also📖PSP Tau Propagation and Spreading Mechanisms45%

see_also📖Pesticides and Parkinson Disease (Pest-PD) — NCT0642031045%

see_also📖A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-C45%

see_also📖Vocational Rehabilitation and Driving in Corticobasal Syndro45%

see_also📖Pseudobulbar Affect and Emotional Lability in Corticobasal S45%

see_also📖Gait and Upper Limb Evaluation in PSP (NCT07136844)45%

see_also📖Somatic Mutations and Brain Mosaicism45%

see_also📖Social Behaviors and Quality of Life in Parkinson's Dis45%

see_also📖Gait and Balance Disorders in Progressive Supranuclear Palsy45%

see_also📖ALS Biomarkers and Disease Monitoring45%

see_also📖Nutritional Support and Dietary Interventions in Corticobasa45%

see_also📖Cognitive and Speech Rehabilitation in CBS (NCT05823421)45%

see_also📖NLRP3 Inhibitors in Parkinson's Disease: Research and C45%

see_also📖Multi-Analyte Biomarker Panel for Parkinson's Disease D45%

see_also📖A Phase III, Randomized, Double-Blind, Placebo-Controlled, M45%

see_also📖Clinical Phenotypes and Subtypes of Corticobasal Syndrome45%

see_also📖Speech and Language Deficits in Corticobasal Syndrome45%

see_also📖Caregiver Support and Palliative Care in Atypical [Parkinson45%

see_also📖alexander-disease45%

see_also📖BLAAC PD - Black and African Americans Connections to PD (NC45%

see_also📖A Phase 3, Randomized, Double-blind, Placebo-controlled, Par45%

see_also📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy45%

see_also📖Alpha-Synuclein Seeding Assays (RT-QuIC and PMCA)45%

see_also📖PSP Liquid-Liquid Phase Separation and Biomolecular Condensa45%

see_also📖Quality of Life and Caregiver Burden in Progressive Supranuc45%

see_also📖TREM2 Gene-Mechanism-Therapy Chain — From Genetic Risk to Th45%

see_also📖Investment Landscape: ALS45%

see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739245%

see_also📖CNversyt and Megan Rodden ALS Trials45%

see_also📖Metabolic Dysfunction and Insulin Resistance in Progressive 45%

see_also📖PSP Weight Loss and Cachexia45%

see_also📖Callosal Disconnection and Interhemispheric Dysfunction in C45%

see_also📖Imaging Biomarkers for Corticobasal Syndrome and Progressive45%

see_also📖Alpha-Synuclein PET Imaging and Biomarker Advances45%

see_also📖Simultanagnosia and Balint's Syndrome in Corticobasal S45%

see_also📖Sleep Architecture Changes in CBS and PSP45%

see_also📖AAIC 2026: Tau-PET Imaging and Fluid Biomarker Integration45%

see_also📖First-in-Human 4R Tau Ligand Study in PSP (NCT07348276)45%

see_also📖TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain45%

see_also📖HIV-Associated Neurocognitive Disorders (HAND)45%

see_also📖FTDP-17 Clinical Phenotypes and Disease Progression45%

see_also📖Silymarin for Neuroprotection and Symptom Management in Park45%

see_also📖Quality of Life and Caregiver Burden in PSP (NCT03638505)45%

see_also📖Iron and Neuromelanin Accumulation in PSP45%

see_also📖Jervell and Lange-Nielsen Syndrome45%

see_also📖Voice and Speech in Corticobasal Syndrome45%

see_also📖Clostridium Butyricum for Motor and Non-motor Symptoms in Pa45%

see_also📖Alexander Disease Genetic Variants45%

see_also📖LRRK2 Kinase Activation and Endolysosomal Dysfunction in Par45%

see_also📖Whole-Body Photobiomodulation for Motor and Cognitive Change45%

see_also📖Speech and Voice Disorders in PSP45%

see_also📖Postural Dysfunction and Abnormalities in Corticobasal Syndr45%

see_also📖LRRK2 Gene Variants and Mutations45%

see_also📖Japanese and German Case Series in Corticobasal Degeneration45%

see_also📖Safety and Clinical Outcomes Study: Amniotic and Umbilical C45%

see_also📖Environmental Toxins and Parkinson's Risk45%

see_also📖Pupillary and Visual Dysfunction in Progressive Supranuclear45%

see_also📖Investment Landscape: Huntington's Disease45%

see_also📖SNCA Gene Variants and Mutations45%

see_also📖GBA Brain Molecular Imaging and Blood Biomarkers for Precisi45%

see_also📖Hemiballismus and Hemichorea in Corticobasal Syndrome45%

see_also📖Sandhoff Disease45%

see_also📖PSP Lysosomal Dysfunction and Autophagy Impairment45%

see_also📖al002-trem2-agonist-alzheimers45%

see_also📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise45%

see_also📖VEGF and Angiogenesis Dysregulation in CBS/PSP45%

mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%

mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%

mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%

mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%

mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%

mentions🔬What are the most promising therapeutic strategies for targe40%

mentions🔬What are the mechanisms underlying blood-brain barrier trans40%

related🧪PARP1 Inhibition Therapy40%

mentions🔬What are the mechanisms underlying senolytic therapy for age40%

mentions🔬Senescent cell clearance as neurodegeneration therapy40%

mentions🔬What are the mechanisms underlying what are the mechanisms b40%

mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%

mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%

mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%

related🧪Ganglioside Rebalancing Therapy40%

Alzheimer's Disease VEGF/Angiogenic Signaling and Cerebral Blood Flow Therapy Companies

💬 Discussion